The pharmacogenomics of paclitaxel in patients with ovarian cancer: predictors of toxicity and response.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Paclitaxel (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Pharmacogenomic; Therapeutic Use
- 13 Jan 2015 Biomarkers information updated
- 22 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Jan 2007 New trial record.